Hydroxyurea therapy in children severely affected with sickle cell disease

Journal of Pediatrics

Volumn 128, Issue 6, 1996, Pages 820-828

  Scott, J P ^a   Hillery, C A ^a   Brown, E R ^a   Misiewicz, V ^a   Labotka, R J ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ADOLESCENT; ARTICLE; BONE MARROW TOXICITY; CLINICAL ARTICLE; CLINICAL FEATURE; DOSE RESPONSE; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN DETERMINATION; HEMOLYTIC ANEMIA; HUMAN; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA; VASOCONSTRICTION;

EID: 0029982591     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(96)70335-9     Document Type: Article

References (33)

1. SH. Embury The clinical pathophysiology of sickle cell disease Ann Rev Med 37 1986 361 376
2. ME Fabry DK. Kaul Sickle cell vaso-occlusion Hematol Oncol Clin North Am 5 1991 375 398
3. MH. Steinberg Sickle cell anemia: pathophysiology, management, and prospects for the future J Clin Apheresis 6 1991 221 223
4. GR Serjeant CDE Ceulaer R Lethbridge J Morris A Singhal PW. Thomas The painful crisis of homozygous sickle cell disease: clinical features Br J Haematol 87 1994 586 591
5. WY Wong DR Powars L Chan A Hiti C Johnson G. Overturf Polysaccharide encapsulated bacterial infection in sickle cell anemia Am J Hematol 39 1992 176 182
6. GD Overturf D Powars LJ. Baraff Bacterial meningitis and septicemia in sickle cell disease Am J Dis Child 131 1977 784
7. C Vermylen G. Cornu Bone marrow transplantation in sickle cell anemia Am J Pediatr Hematol Oncol 16 1994 67 71
8. FL Johnson WC Mentzer KA Kalinyak KM Sullivan MR. Abboud Bone marrow transplantation for sickle cell disease: the United States Experience Am J Pediatr Hematol Oncol 16 1994 22 26
9. AS Wayne SV Kevy DG. Nathan Transfusion management of sickle cell disease Blood 81 1993 1109 1123
10. EP Vichinsky A Earles RA Johnson MS Hoag A Williams B. Lubin Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood N Engl J Med 322 1990 1617 1621
11. AR Cohen GR Buchanan M Martin K. Ohene-Frempong Increased blood requirements during long-term transfusion therapy for sickle cell disease J Pediatr 118 1991 405 407
12. RY. Dodd The risk of transfusion-transmitted infection [Editorial] N Engl J Med 327 1992 419 421
13. D Powars JN Weirs LS Chan WA. Schroeder Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia? Blood 63 1984 921 926
14. MH Steinberg BL. Dreiling Clinical, hematologic and biosynthetic studies in sickle cell-beta-thalassemia: a comparison with sickle cell anemia Am J Hematol 1 1976 35 44
15. C Atlay WA Schroeder THJ. Huisman The G gamma-delta-beta thalassemia and G gamma-beta-HPHF conditions in combination with beta-thalassemia and Hb-S Am J Hematol 3 1977 1 4
16. HF Bunn BG. Forget Hemoglobin: molecular, genetic and clinical aspects 1986 Saunders Philadelphia
17. CT Noguchi GP Rodgers G Serjeant AN. Schechter Levels of fetal hemoglobin necessary for treatment of sickle cell disease N Engl J Med 318 1988 96 99
18. S Charache GJ Dover RD Moore Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia Blood 79 1992 2555 2565
19. JA Stamatoyannopoulos AW. Neinhuis Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies Annu Rev Med 43 1992 497 521
20. S. Charache Hydroxyurea as treatment for sickle cell anemia Hematol Oncol Clin North Am 5 1991 571 583
21. S Charache ML Terrin RD Moore Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia N Engl J Med 332 1995 1317 1322
22. D Brookoff R. Polomano Treating sickle cell pain like cancer pain Ann Intern Med 116 1992 364 368
23. GP Rodgers GJ Dover CT Nogucki AN Schechter AW. Neinhuis Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea N Engl J Med 322 1990 1037 1045
24. OS Platt BD Thorington DJ Brambilla Pain in sickle cell disease: rates and risk factors N Engl J Med 325 1991 11 16
25. JP Scott VM Misiewicz E Robinson CA Hillery RJ. Labotka Long-term follow-up of severely affected children with sickle cell disease (SCD) treated with hydroxyurea (HDU) [abstract] National Sickle Cell Disease Program, 20th Annual Meeting, Boston 1995
26. K Ohene-Frempong K Horiuchi CJ Stoeckert Sustained effect of hydroxyurea on Hb F production in children with sickle cell disease National Sickle Cell Disease Program, 20th Annual Meeting, Boston 1995 215
27. de-M Montalembert F Bernaudin R Ducrocq Clinical and hematological response of sickle cell children to treatment with hydroxyurea [abstract] Blood 84 Suppl 1994 219a
28. EP Vichinsky BH. Lubin A cautionary note regarding hydroxyurea in sickle cell disease Blood 83 1994 1124 1128
29. B Berman K. Chiarucci Avascular necrosis of the femoral head in a child with sickle cell anemia receiving hydroxyurea therapy [abstract] National Sickle Cell Disease Program, 20th Annual Meeting, Boston 1995 136
30. DT Kaung AA. Swarzenbdruber Effect of chemotherapeutic agents in chromosomes of patients with lung cancer Dis Chest 55 1969 98 100
31. KS. Khera Teratogenicity study on hydroxyurea and diphenylhydantoin in cats Teratology 20 1970 447 452
32. JW. Yarbro Mechanism of action of hydroxyurea Semin Oncol 19 1992 1 10
33. GJ Dover S. Charache Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease Semin Oncol 19 1992 61 66